无症状遗传性抗凝血酶、蛋白C和蛋白S缺陷儿童静脉血栓栓塞症的前瞻性队列研究
本研究前瞻性纳入87个家系的134名儿童,其中70名为遗传性抗凝血酶、蛋白C或蛋白S缺陷携带者,64名非携带者。携带者随访287观察年发生6例VTE,年发病率2.09%(95%CI 0.8-4.5),非携带者248观察年无VTE发生。14名携带者经历血栓风险期,其中4名(28.6%)发生VTE,风险期相关VTE发生率为每风险期25%(95%CI 6.8-64)。
要点
- 遗传性易栓症儿童携带者年VTE发病率为2.09%(95%CI 0.8-4.5)
- 经历风险期的携带者中28.6%发生VTE,每风险期发生率25%(95%CI 6.8-64)
- 建议对这类家系中的儿童进行易栓症筛查以识别风险期需血栓预防者
核心结论
- 严重遗传性易栓症儿童的血栓风险似乎与具有相同缺陷的成人相当。
- 对存在这些缺陷家系的儿童进行易栓症筛查似乎合理,以识别可能在血栓风险期受益于血栓预防的儿童。
研究设计与样本
- 前瞻性队列研究,纳入87个家系的134名儿童,其中70名(51.5%)为遗传性缺陷携带者,64名为非携带者。
- 携带者平均观察4年(范围1-16年),非携带者平均观察3.9年(范围1-13年)。
主要发现
- 70名携带者在287观察年中共发生6例VTE,年发病率为2.09%(95%CI 0.8-4.5)。
- 64名非携带者在248观察年期间无VTE发生。
- 14名经历血栓风险期的易栓症儿童中,4名(28.6%)发生VTE。
- 风险期相关VTE总体发生率为每风险期25%(95%CI 6.8-64)。
临床怎么用
- 对于遗传性抗凝血酶、蛋白C或蛋白S缺陷家系中的儿童,可考虑进行易栓症筛查。
- 筛查可识别可能在血栓风险期受益于血栓预防的儿童。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although antithrombin, protein C, and protein S defects are well-recognized inherited risk factors for venous thromboembolism (VTE) in adults, whether they predispose children to these vascular disorders as well is undefined. In a prospective cohort study, we assessed the incidence of spontaneous and risk period-related VTE in children who were family members of adults who, after an episode of symptomatic VTE, had then been identified as carriers of these abnormalities. A total of 134 children from 87 families were enrolled. Seventy (51.5%) of these children were carriers of an inherited defect, and the remaining 64 were not; the mean observation period was 4 years (range, 1-16 years) and 3.9 years (range, 1-13), respectively. Sixteen risk periods were experienced by carriers, and 9 by noncarriers. Six VTE occurred in the 70 carriers during 287 observation-years, accounting for an annual incidence of 2.09% patient-years (95% confidence interval, 0.8-4.5), compared with none in the 64 noncarriers during 248 observation-years. Of the 14 children with thrombophilia who experienced a risk period for thrombosis, 4 (28.6%) developed a VTE episode. The overall incidence of risk-related VTE was 25% per risk period (95% confidence interval, 6.8-64). In conclusion, the thrombotic risk in otherwise healthy children with severe inherited thrombophilia does not seem to differ from that reported for adults with the same defects. Screening for thrombophilia in children who belong to families with these defects seems justified to identify those who may benefit from thromboprophylaxis during risk periods for thrombosis.
引用
- Tormene D, Campello E, Simion C, et al. Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study. Blood Adv. 2020. PMID: 33156924. doi:10.1182/bloodadvances.2020002781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。